https://openbell.ai/ 2026-10-19T16:38:46.870Z hourly 1.0 https://openbell.ai/support 2026-10-19T16:38:46.870Z monthly 0.7 https://openbell.ai/privacy 2026-10-19T16:38:46.870Z monthly 0.5 https://openbell.ai/terms 2026-10-19T16:38:46.870Z monthly 0.5 https://openbell.ai/feed.json 2026-10-19T16:38:46.870Z hourly 0.8 https://openbell.ai/news/TSLA:1792427907265 2026-10-19T16:38:27.265Z daily 0.9 https://cdn.brandfetch.io/TSLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tesla Stock Trends Higher: What's Going On? Tesla Inc (NASDAQ: TSLA) shares increased by 4.03% to $369.02 ahead of its third-quarter earnings report scheduled for October 21, which is expected to show earnings of 43 cents per share on $27.88 billion in sales. This follows a previous quarter where sales rose 26% to $28.24 billion, but operating income fell 57%. Additionally, speculation surrounding a potential merger with SpaceX has intensified following the recent reveal of Tesla's second-generation Roadster, which incorporates SpaceX technology. Analysts maintain a consensus Buy rating for Tesla, with an average price target of $415. https://openbell.ai/news/WULF:1792427902456 2026-10-19T16:38:22.456Z daily 0.9 https://cdn.brandfetch.io/WULF/w/400/h/400?c=1idopYfmtR7ZKg8QMud TeraWulf shares are trading higher alongside a rally in AI cloud service companies. The CEO posted on social media that TeraWolf is an energy infrastructure company that matches long-term investment-grade energy supplies with long-term HPC/AI offtake. openbell Financial News https://openbell.ai/news/TSLA:1792427695024 2026-10-19T16:34:55.024Z daily 0.9 https://cdn.brandfetch.io/TSLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tesla shares are trading higher after reports suggesting that the company's merger with SpaceX may be moving closer to becoming a reality, with prediction market lines for the possibility of that event moving well above 50%. openbell Financial News https://openbell.ai/news/TEAM:1792427671525 2026-10-19T16:34:31.525Z daily 0.9 https://cdn.brandfetch.io/TEAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Atlassian, Raises Price Target to $280 Guggenheim analyst Howard Ma has maintained a Buy rating on Atlassian (NASDAQ: TEAM) and increased the price target from $165 to $280. This adjustment reflects the firm's positive outlook on the company's performance. https://openbell.ai/news/UNP:1792427667201 2026-10-19T16:34:27.201Z daily 0.9 https://cdn.brandfetch.io/UNP/w/400/h/400?c=1idopYfmtR7ZKg8QMud U.S. Transportation Secretary Sean P. Duffy Announces Over $2.3B Investment Into Rail Infrastructure, Safety Across America U.S. Transportation Secretary Sean P. Duffy announced an investment of over $2.3 billion aimed at enhancing rail infrastructure and safety across the United States. This initiative is part of a broader effort to improve transportation systems nationwide. The announcement may have implications for companies in the rail industry, including Union Pacific Corporation (UNP), as it could lead to increased demand for rail services and infrastructure development. https://openbell.ai/news/IRON:1792427606433 2026-10-19T16:33:26.433Z daily 0.9 https://cdn.brandfetch.io/IRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud Disc Medicine Delivers Promise For Patients with Sunlight Sensitivity In Successful Pivotal Study Disc Medicine Inc. (NASDAQ: IRON) reported positive topline results from its APOLLO Phase 3 trial for bitopertin, a treatment for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), achieving all primary and secondary endpoints. The trial showed a 41.4% reduction in whole-blood metal-free PPIX and an average increase of 12.2 hours in light exposure without pain. Following these results, the company plans to resubmit a new drug application to the U.S. FDA by year-end, with a decision expected by mid-2027. Disc Medicine's shares rose 26.07% to $71.66 on the announcement. https://openbell.ai/news/ARQT:1792427594625 2026-10-19T16:33:14.625Z daily 0.9 https://cdn.brandfetch.io/ARQT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $44 Guggenheim analyst Seamus Fernandez has maintained a Buy rating on Arcutis Biotherapeutics (NASDAQ: ARQT) and increased the price target from $38 to $44. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/TRV:1792427545141 2026-10-19T16:32:25.141Z daily 0.9 https://cdn.brandfetch.io/TRV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Travelers Companies Is Likely ‘Overearning,’ Says Bearish Analyst Travelers Companies Inc (NYSE: TRV) is facing scrutiny from BofA Securities, which maintains an Underperform rating and a price target of $333, citing concerns that the company is 'overearning' despite recent large earnings beats. Analyst Joshua Shanker noted that while profits in auto and home insurance have reached record highs, the company is losing market share, with policy counts declining by 3.1% and 4.0% respectively over the past year. Additionally, Travelers' shares fell 0.93% to $385.90, and the analyst highlighted that the company’s historical earnings growth through stock buybacks is becoming less effective due to high stock prices. https://openbell.ai/news/ANNX:1792427514437 2026-10-19T16:31:54.437Z daily 0.9 https://cdn.brandfetch.io/ANNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Annexon shares are trading higher after HC Wainwright & Co. raised its price target on the stock from $14 to $25. openbell Financial News https://openbell.ai/news/AMD:1792427490485 2026-10-19T16:31:30.485Z daily 0.9 https://cdn.brandfetch.io/AMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of semiconductor and chip companies are trading higher as the sector rebounds from last week's weakness, with CoreWeave, the bellwether, rising on a Goldman Sachs upgrade. The Philadelphia Semiconductor Index is expected to end its longest losing streak since the 2008 financial crisis. openbell Financial News https://openbell.ai/news/AMD:1792427463162 2026-10-19T16:31:03.162Z daily 0.9 https://cdn.brandfetch.io/AMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is AMD Stock Surging on Monday? Advanced Micro Devices Inc (NASDAQ: AMD) stock rose 4.05% to $550.18 on Monday, driven by a rebound in the semiconductor sector following a Goldman Sachs upgrade of CoreWeave Inc. The Philadelphia Semiconductor Index increased by 3.1%, marking its strongest performance since September 21, after experiencing a decline of 15.74% over eight consecutive sessions. Broader market indexes also advanced, with the Nasdaq up 1.94% and the S&P 500 gaining 0.86%. https://openbell.ai/news/HPP:1792427438707 2026-10-19T16:30:38.707Z daily 0.9 https://cdn.brandfetch.io/HPP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hudson Pacific Properties shares are trading lower after Piper Sandler downgraded the stock from Overweight to Neutral rating and lowered the price target from $15 to $13. openbell Financial News https://openbell.ai/news/PLTR:1792427416893 2026-10-19T16:30:16.893Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of AI cloud services companies are trading higher as the sector rebounds from recent weakness after Goldman Sachs upgraded CoreWeave, easing concerns about AI infrastructure. openbell Financial News https://openbell.ai/news/GSK:1792427356980 2026-10-19T16:29:16.980Z daily 0.9 https://cdn.brandfetch.io/GSK/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Approves Immunotherapy That May Allow Certain Patients With Rectal Cancer To Avoid Chemotherapy, Radiation And Surgery The FDA has approved a new immunotherapy treatment that may enable specific patients with rectal cancer to bypass traditional chemotherapy, radiation, and surgery. This approval could significantly impact treatment protocols for rectal cancer, potentially improving patient outcomes. The stock ticker for the company involved in this development is GSK. https://openbell.ai/news/MAZE:1792427354048 2026-10-19T16:29:14.048Z daily 0.9 https://cdn.brandfetch.io/MAZE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Maze Therapeutics shares are trading higher after Canaccord Genuity initiated coverage on the stock with a Buy rating and announced a $75 price target. openbell Financial News https://openbell.ai/news/BILL:1792427198504 2026-10-19T16:26:38.504Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Bill-com-Logo-At-Headquarters--Bill-com-.jpg?width=250&height=187 BILL Unveils New AI-Powered Finance Tools, Payment Volume Crosses $2 Trillion Milestone BILL Holdings, Inc. (NYSE: BILL) has launched a new suite of AI-powered finance tools aimed at enhancing payment security and workflow automation. The company recently surpassed $2 trillion in cumulative total payment volume since its inception. BILL's stock is currently trading at $45.73, up 0.30%, with analysts projecting earnings of 96 cents per share and revenue of $439.47 million for the upcoming Nov. 5 earnings report. https://openbell.ai/news/SLGN:1792427158627 2026-10-19T16:25:58.627Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/MA.jpg?width=250&height=187 Silgan Seals $3.4B Trivium Deal, Keeps 60% Control Of $7.3B Packaging Business Silgan Holdings Inc. has agreed to acquire Trivium Packaging B.V. for approximately $3.4 billion in an all-cash transaction, which will combine Trivium with Silgan's existing metal packaging businesses to form Silgan Metal Containers and Closures, valued at about $7.3 billion. The deal is expected to generate $225 million in synergies by the end of year three and drive at least 15% accretion to adjusted EPS and free cash flow. Silgan will retain a 60% controlling stake in the new entity, with American Industrial Partners owning the remaining 40%. Following the announcement, Silgan's shares rose 6.24% to $40.16. https://openbell.ai/news/XE:1792427064691 2026-10-19T16:24:24.691Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/3d-Rendering-Smr-Or-Small-Modular-Nuclea.jpg?width=250&height=187 X-Energy Expands Nuclear Pipeline With New Indiana Reactor Proposal X-Energy, Inc. (NASDAQ: XE) has signed a joint development agreement with American Electric Power (NASDAQ: AEP) to assess a proposed 960-megawatt small modular reactor project in Indiana, which will utilize AEP's site and X-energy's reactor technology. Amazon.com, Inc. (NASDAQ: AMZN) will fund certain development activities for this project, which aims to add over 5 gigawatts of nuclear capacity to the U.S. power grid by 2039. This proposal marks X-Energy's third announced U.S. Xe-100 project, contributing to its 11.5-gigawatt commercial pipeline. Following the announcement, X-Energy's shares rose by 0.48% to $10.41. https://openbell.ai/news/REGN:1792427014637 2026-10-19T16:23:34.637Z daily 0.9 https://cdn.brandfetch.io/REGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Overweight on Regeneron Pharmaceuticals, Raises Price Target to $865 Piper Sandler analyst Biren Amin has maintained an Overweight rating on Regeneron Pharmaceuticals (NASDAQ: REGN) and raised the price target from $854 to $865. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/BBIO:1792426886778 2026-10-19T16:21:26.778Z daily 0.9 https://cdn.brandfetch.io/BBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Overweight on BridgeBio Pharma, Raises Price Target to $120 Piper Sandler analyst Biren Amin has maintained an Overweight rating on BridgeBio Pharma (NASDAQ: BBIO) and increased the price target from $115 to $120. https://openbell.ai/news/TSLA:1792426871094 2026-10-19T16:21:11.094Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Elon-Musk--The-Ceo-Of-Tesla--Spacex--Pay.jpg?width=250&height=187 SpaceX Could Buy Tesla for $480 Per Share in $3.74 Trillion Merger, RBC Says RBC Capital Markets has suggested that SpaceX could acquire Tesla for $480 per share, creating a combined company valued at $3.74 trillion. Tesla shareholders would own 48% of the merged entity, down from 54% in previous estimates due to SpaceX's rising valuation. The proposed deal represents a 30% premium for Tesla investors, who would receive SpaceX shares instead of cash. Tesla shares rose over 3% to $367, while SpaceX shares increased by over 2% to $150. https://openbell.ai/news/RXRX:1792426712365 2026-10-19T16:18:32.365Z daily 0.9 https://cdn.brandfetch.io/RXRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Recursion Pharmaceuticals shares are trading after Needham reiterated its Buy rating on the stock and maintained a $8 price target. openbell Financial News https://openbell.ai/news/CDNA:1792426487877 2026-10-19T16:14:47.877Z daily 0.9 https://cdn.brandfetch.io/CDNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud CareDx shares are trading higher after Canaccord Genuity maintained its Buy rating on the stock and raised its price target from $65 to $80. openbell Financial News https://openbell.ai/news/XE:1792426479379 2026-10-19T16:14:39.379Z daily 0.9 https://cdn.brandfetch.io/XE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Underweight on X-Energy, Lowers Price Target to $8 Piper Sandler analyst Dimple Gosai has maintained an Underweight rating on X-Energy (NASDAQ: XE) and has reduced the price target from $9 to $8. This adjustment reflects the firm's cautious outlook on the company's performance. https://openbell.ai/news/SLGN:1792426203551 2026-10-19T16:10:03.551Z daily 0.9 https://cdn.brandfetch.io/SLGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Silgan Holdings shares are trading higher after the company announced it will combine with Trivium Packaging. openbell Financial News https://openbell.ai/news/BCS:1792426176517 2026-10-19T16:09:36.517Z daily 0.9 https://cdn.brandfetch.io/BCS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays shares are trading lower after reports suggesting the Bank of England is examining claims that traders misrepresented the company's exposure to private credit. openbell Financial News https://openbell.ai/news/MA:1792426158266 2026-10-19T16:09:18.266Z daily 0.9 https://cdn.brandfetch.io/MA/w/400/h/400?c=1idopYfmtR7ZKg8QMud MasterCard Introduces Risk Intelligence To Enable More Secure Stablecoin Payments MasterCard has launched a new Risk Intelligence solution aimed at enhancing the security of stablecoin payments. This initiative is part of the company's broader strategy to integrate blockchain technology into its payment systems. The introduction of this technology is expected to improve transaction safety and mitigate risks associated with digital currencies. https://openbell.ai/news/AAPL:1792426061114 2026-10-19T16:07:41.114Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Apple-iPhone-Duo.jpg?width=250&height=187 Apple iPhone Duo Has 82-Day Lead Time: Analyst Names Tech Giant 'Eventual' AI Winner Apple Inc's (NASDAQ: AAPL) iPhone Duo foldable smartphone has generated strong demand, with an average global ship time of 82 days as of October 19. Bank of America Securities analyst Wamsi Mohan maintains a Buy rating on Apple stock with a price target of $370, noting that the lead time for the Duo extends into 2027. The company's stock price is currently at $342.89, down 0.2%, but up 26.5% year-to-date and has recently reached all-time highs. https://openbell.ai/news/SEIC:1792426017538 2026-10-19T16:06:57.538Z daily 0.9 https://cdn.brandfetch.io/SEIC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Overweight on SEI Investments, Raises Price Target to $127 Piper Sandler analyst Crispin Love has maintained an Overweight rating on SEI Investments (NASDAQ: SEIC) and increased the price target from $120 to $127. https://openbell.ai/news/LHX:1792426017020 2026-10-19T16:06:57.020Z daily 0.9 https://cdn.brandfetch.io/LHX/w/400/h/400?c=1idopYfmtR7ZKg8QMud L3Harris Technologies Receives ~$877M U.S. Navy Contract For Engineering, Manufacturing Phase Of Jammer Low Band Program L3Harris Technologies (NYSE: LHX) has been awarded a contract modification from the U.S. Navy valued at approximately $876.4 million for the engineering and manufacturing phase of the Next Generation Jammer Low Band program. This contract supports an accelerated timeline for the program, which aligns with the Department of War's priority to enhance capabilities for the warfighter. https://openbell.ai/news/CTSH:1792425969652 2026-10-19T16:06:09.652Z daily 0.9 https://cdn.brandfetch.io/CTSH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cognizant, Google Cloud Expand Collaboration Over Adoption Of Agentic AI Cognizant (NASDAQ: CTSH) and Google Cloud have expanded their partnership to enhance the adoption of agentic AI, launching the new Gemini Frontier Capability Group. This initiative combines Google's AI platform with Cognizant's industry expertise, creating a dedicated global workforce aimed at advancing AI solutions. https://openbell.ai/news/NNOX:1792425532854 2026-10-19T15:58:52.854Z daily 0.9 https://cdn.brandfetch.io/NNOX/w/400/h/400?c=1idopYfmtR7ZKg8QMud NANO-X IMAGING shares are trading lower after the company issued Q3 sales guidance below estimates. openbell Financial News https://openbell.ai/news/SNOW:1792425405048 2026-10-19T15:56:45.048Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Warsaw--Poland--31-July-2024--Wola-Busin.jpg?width=250&height=187 Why Is Snowflake Stock Surging Monday? Snowflake Inc. (NYSE: SNOW) stock rebounded by 3.30% to $316.97 on Monday after a selloff on Friday, as investors returned to technology stocks amidst broader market gains, with the Nasdaq Composite rising 1.59%. Despite concerns over rising debt levels and a Gartner report on neocloud providers, Wall Street analysts remain bullish, with 31 out of 35 recommending a Buy rating and an average price forecast of $402, indicating a potential upside of about 27%. Technical analysis shows the stock is in a long-term uptrend, trading 6.9% above its 100-day SMA, but faces near-term selling pressure, with key resistance at $348.50 and support at $317. https://openbell.ai/news/NFLX:1792425403217 2026-10-19T15:56:43.217Z daily 0.9 https://cdn.brandfetch.io/NFLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud 18 Globo Titles Heading To Netflix In Unprecedented Licensing Agreement Netflix has entered into a licensing agreement with Globo to stream 18 titles from the Brazilian media company. This unprecedented deal expands Netflix's content library and strengthens its position in the Latin American market. The specific financial terms of the agreement have not been disclosed, but it is expected to enhance subscriber engagement and attract new viewers. https://openbell.ai/news/IBRX:1792425143176 2026-10-19T15:52:23.176Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/San-Diego--Ca--Usa---July-9--2022-Immuni.jpg?width=250&height=187 ImmunityBio Study Shows Long-Term Success for Bladder Cancer Treatment ImmunityBio, Inc. (NASDAQ: IBRX) reported promising results from its Phase 2/3 QUILT-3.032 study of its immunotherapy treatment, ANKTIVA, showing a 71% complete response rate and a median response duration of 26.6 months for patients with BCG-unresponsive non-muscle invasive bladder cancer. The study also indicated an 84% cystectomy-free survival rate at 36 months and a 98.2% disease-specific survival rate at three years, with no severe treatment-related adverse events reported. ImmunityBio's stock has increased by 255.13% over the past year, trading at $9.609, up 4.68% on Monday. https://openbell.ai/news/VAI:1792425046909 2026-10-19T15:50:46.909Z daily 0.9 https://cdn.brandfetch.io/VAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Valor Energy shares are trading higher after the company announced that will acquire a 18MW computing center. openbell Financial News https://openbell.ai/news/TTMI:1792424968820 2026-10-19T15:49:28.820Z daily 0.9 https://cdn.brandfetch.io/TTMI/w/400/h/400?c=1idopYfmtR7ZKg8QMud TTM Technologies shares are trading higher after the company announced that it has entered into a definitive agreement to acquire the Ophir Optics business from MKS for approximately $650 million in an all-cash transaction. openbell Financial News https://openbell.ai/news/RKLB:1792424738453 2026-10-19T15:45:38.453Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/RocketLab.jpg?width=250&height=187 Rocket Lab Stock Climbs: What's Happening? Rocket Lab Corp (NASDAQ: RKLB) shares rose 3.34% to $52.54 following an Overweight rating from Cantor Fitzgerald, which maintained a price target of $122 despite a delay in the Neutron launch to 2027 due to production issues. The company is also pursuing a deal to acquire Iridium Communications Inc for $54 per share, which could potentially double Rocket Lab's revenue, with projections of $939.8 million for fiscal 2026. Analysts believe the revenue synergies from the Iridium acquisition have not yet been fully reflected in current estimates. https://openbell.ai/news/EXYN:1792424721999 2026-10-19T15:45:21.999Z daily 0.9 https://cdn.brandfetch.io/EXYN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Exyn Technologies shares are trading higher after the company announced that it joined a Department of Energy-backed mining project to hunt for critical metals. openbell Financial News https://openbell.ai/news/MU:1792424272952 2026-10-19T15:37:52.952Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Micron.jpg?width=250&height=187 Why Micron and Sandisk Stocks Are Surging Monday Micron Technology Inc. (NASDAQ: MU) and Sandisk Corp. (NASDAQ: SNDK) saw their stocks rise on Monday, with Micron up 5.13% to $923.93 and Sandisk up 7.56% to $1397.55, following a broader recovery in technology stocks after last week's selloff. Investors are regaining confidence amid strong demand for memory products used in AI data centers, despite previous concerns over competition from Chinese chipmaker ChangXin Memory Technologies. Analysts suggest that while AI demand supports growth, the memory sector faces challenges from moderating price increases and potential competition. https://openbell.ai/news/GPK:1792424209622 2026-10-19T15:36:49.622Z daily 0.9 https://cdn.brandfetch.io/GPK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Underweight on Graphic Packaging Holding, Lowers Price Target to $9 Wells Fargo analyst Richard Carlson has maintained an Underweight rating on Graphic Packaging Holding (NYSE: GPK) and has lowered the price target from $10 to $9. https://openbell.ai/news/NFLX:1792423900508 2026-10-19T15:31:40.508Z daily 0.9 https://cdn.brandfetch.io/NFLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Dan Lin Out as Netflix Film Chief' - Variety Dan Lin is stepping down from his position as the head of Netflix's film division. His departure comes amid ongoing changes within the company as it seeks to adapt to a competitive streaming landscape. Netflix has not yet announced a successor or provided details on the reasons behind Lin's exit. https://openbell.ai/news/BTCUSD:1792423769422 2026-10-19T15:29:29.422Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Dalio--Dimon-Warn-Of-Debt-Crisis-And-Bon.jpg?width=250&height=187 Could Bitcoin's Next Big Catalyst Come From the $300 Trillion Bond Market? Bitcoin (BTC) may see growth as it targets the $300 trillion global bond market through BTC-backed credit products, according to Richard Byworth of BYZ Partners. Strategy (NASDAQ:MSTR) is launching perpetual preferred equity products that offer yields backed by Bitcoin-heavy corporate balance sheets. Byworth noted that several countries are considering Bitcoin-backed bonds for financing energy infrastructure, which could reduce reliance on traditional lenders. Currently, Bitcoin is consolidating around $82,000, with signs of selling pressure nearing exhaustion. https://openbell.ai/news/TRV:1792423673270 2026-10-19T15:27:53.270Z daily 0.9 https://cdn.brandfetch.io/TRV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Equal-Weight on Travelers Companies, Raises Price Target to $377 Wells Fargo analyst Elyse Greenspan has maintained an Equal-Weight rating on Travelers Companies (NYSE: TRV) and raised the price target from $341 to $377. This adjustment reflects a positive outlook for the company while keeping the stock rating unchanged. https://openbell.ai/news/TSCO:1792423586778 2026-10-19T15:26:26.778Z daily 0.9 https://cdn.brandfetch.io/TSCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Tractor Supply, Raises Price Target to $36 Wells Fargo analyst Zachary Fadem has maintained an Overweight rating on Tractor Supply Company (NASDAQ: TSCO) and has raised the price target from $35 to $36. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/MTCH:1792423288611 2026-10-19T15:21:28.611Z daily 0.9 https://cdn.brandfetch.io/MTCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Match Group shares are trading higher after Evercore ISI Group upgraded the stock from In-Line to Outperform and raise its price target from $39 to $53. openbell Financial News https://openbell.ai/news/ESLT:1792423142971 2026-10-19T15:19:02.971Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Elbit-Systems-Photo-by-T--Schneider-via-.jpg?width=250&height=187 Elbit Systems Secures $235 Million European Defense Deal Elbit Systems Ltd. has secured a $235 million contract to supply EXTRA-MR rockets and PULS rocket artillery systems to a European customer, under a government-to-government agreement. The three-year deal includes additional rocket artillery platforms and integrated logistics support. Following the announcement, Elbit's stock rose by 0.19% to $756.87, and the company has seen a 53.97% increase in stock value over the past year. https://openbell.ai/news/BTCUSD:1792423115168 2026-10-19T15:18:35.168Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/19/Golden-Bitcoin-Coin-In-Red-And-Blue-Smok.jpg?width=250&height=187 'Of Course' Bitcoin Could Grow to $50 Trillion, Jordi Visser Says: But How? Macro investor Jordi Visser suggests that Bitcoin (BTC) could potentially reach a $50 trillion valuation, citing its recent performance as a safe asset amidst market volatility. He attributes the current market selloff to leveraged hedge funds rather than issues with AI stocks, noting that Bitcoin has maintained a trading range between $82,000 and $85,000 for four months. Visser anticipates significant movements in both AI stocks and Bitcoin following hyperscaler earnings reports later this month and again in December, as many funds reduce risk for the year. https://openbell.ai/news/EIDO:1792422912373 2026-10-19T15:15:12.373Z daily 0.9 https://cdn.brandfetch.io/EIDO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of U.S.-listed Indonesian companies are trading lower amid continued weakness after the MSCI recently launched a consultation on a proposal to reclassify the MSCI Indonesia Indexes from Emerging Market to Standalone Market status. openbell Financial News https://openbell.ai/news/NVS:1792422799352 2026-10-19T15:13:19.352Z daily 0.9 https://cdn.brandfetch.io/NVS/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Grants Orphan Drug Designation To Novartis’ Rapcabtagene Autoleucel For Treatment Of Idiopathic Inflammatory Myopathies The FDA has granted orphan drug designation to Novartis' Rapcabtagene Autoleucel for the treatment of idiopathic inflammatory myopathies. This designation is intended to encourage the development of treatments for rare diseases. The approval may impact Novartis' market position in the specialty pharmaceuticals sector, although specific financial implications were not detailed in the article.